Stockscreener 앱 받기
4.23
13.40%
0.50
시간 외 거래:
4.32
0.09
+2.13%
전일 마감가:
$3.73
열려 있는:
$3.93
하루 거래량:
3.56M
Relative Volume:
1.50
시가총액:
$696.31M
수익:
$361.51M
순이익/손실:
$102.18M
주가수익비율:
7.0807
EPS:
0.5974
순현금흐름:
$112.21M
1주 성능:
+14.02%
1개월 성능:
+0.48%
6개월 성능:
-13.50%
1년 성능:
+453.66%
1일 변동 폭
$3.87
$4.275
1주일 범위
$3.55
$4.275
52주 변동 폭
$0.715
$5.78
아이언우드 제약 Stock (IRWD) Company Profile
명칭
Ironwood Pharmaceuticals Inc
전화
617-621-7722
주소
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Compare IRWD vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IRWD
Ironwood Pharmaceuticals Inc
|
4.23 | 643.64M | 361.51M | 102.18M | 112.21M | 0.5974 |
TAK
Takeda Pharmaceutical Co Adr
|
17.10 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.855 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.01 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
77.28 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
517.71 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
아이언우드 제약 Stock (IRWD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-04-15 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-04-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-04-14 | 다운그레이드 | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2024-09-09 | 개시 | Leerink Partners | Market Perform |
| 2024-08-08 | 다운그레이드 | CapitalOne | Overweight → Equal Weight |
| 2024-01-17 | 개시 | Craig Hallum | Buy |
| 2023-12-14 | 개시 | Wells Fargo | Overweight |
| 2023-11-09 | 개시 | Jefferies | Buy |
| 2023-09-28 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-02 | 개시 | CapitalOne | Overweight |
| 2022-04-22 | 개시 | Piper Sandler | Overweight |
| 2020-09-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-06-17 | 개시 | Northland Capital | Outperform |
| 2019-07-10 | 재개 | Credit Suisse | Neutral |
| 2019-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-02-25 | 업그레이드 | H.C. Wainwright | Sell → Neutral |
| 2019-01-24 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2018-11-07 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2018-11-07 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2018-07-23 | 개시 | H.C. Wainwright | Sell |
| 2018-05-09 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-01-05 | 다운그레이드 | BofA/Merrill | Buy → Underperform |
| 2017-12-06 | 다운그레이드 | Mizuho | Buy → Neutral |
| 2017-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2017-05-03 | 개시 | Wells Fargo | Outperform |
| 2017-04-07 | 재확인 | Mizuho | Buy |
| 2017-02-22 | 재확인 | Barclays | Equal Weight |
| 2016-11-04 | 재확인 | Mizuho | Buy |
| 2016-10-24 | 재확인 | Wedbush | Neutral |
| 2016-10-10 | 재확인 | Mizuho | Buy |
| 2016-09-27 | 재확인 | WallachBeth | Hold |
모두보기
아이언우드 제약 주식(IRWD)의 최신 뉴스
Ironwood Pharmaceuticals Inc (IRWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Institutional Confidence - TradingKey
Return on assets % of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView
Total operating expenses of Ironwood Pharmaceuticals, Inc. Class A – HAM:I76 - TradingView
Ironwood Pharmaceuticals Inc (IRWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – BX:I76 - TradingView
Ironwood Pharmaceuticals, Inc. Class A Revenue Breakdown – SWB:I76 - TradingView
Ironwood Pharmaceuticals Inc (IRWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
IRWD|Ironwood Pharmaceuticals Inc|Price:3.910|Chg%:+0.200 - TradingKey
Ironwood Pharmaceuticals Inc (IRWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRWD|Ironwood Pharmaceuticals Inc|Price:3.710|Chg%:-0.080 - TradingKey
Ironwood Pharmaceuticals Inc (I76.MU) Stock Price, News, Quote & History - Yahoo! Finance Canada
IRWD: Ironwood Pharmaceuticals IncOrdinary SharesClass A Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
Ironwood Pharmaceuticals (IRWD) grants 137,036-share RSU new-hire award to CMO - Stock Titan
Ironwood Pharmaceuticals (IRWD) Jefferies 2024 Global Healthcare Conference Summary - Quartr
Craig-Hallum Maintains Ironwood Pharmaceuticals(IRWD.US) With Buy Rating - Moomoo
Ironwood Appoints Dr. Jeffrey Silber Chief Medical Officer and Head of Research and Drug Development, STARS-2 Trial Initiated in June and Is Now Actively Recruiting Patients - marketscreener.com
Here's why Ironwood Pharmaceuticals (IRWD) is a strong momentum stock - MSN
Ironwood’s 30-year medical chief retires as Phase 3 trial recruits - Stock Titan
Ironwood: Linzess Buys Time, But Apraglutide's rNPV Doesn't Close The Gap (NASDAQ:IRWD) - Seeking Alpha
Insider Sell Alert: Ronald Silver Sells Shares of Ironwood Pharm - GuruFocus
Form 4 Ironwood Pharmaceuticals Inc For: 9 July - Investing.com India
Form 4 Ironwood Pharmaceuticals Inc For: 9 July By Investing.com - Investing.com Nigeria
Ironwood Pharmaceuticals (IRWD) Declines 2.1% as Stock Approaches Key Support LevelNHNL Ratio - dars.gov.et
Ronald Silver, PFO, sells $578k in Ironwood Pharma stock By Investing.com - Investing.com Nigeria
Ronald Silver, PFO, sells $578k in Ironwood Pharma stock - Investing.com
Ironwood (IRWD) finance chief sells 127,890 shares in 10b5-1 stock plan - Stock Titan
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (NASDAQ:IRWD) - TradingView
Form 144 IRONWOOD PHARMACEUTICALS For: 7 July By Investing.com - Investing.com Nigeria
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Proposed Common stock sale for IRWD (NASDAQ: IRWD) via Morgan Stanley Smith Barney - Stock Titan
Enterprise value to EBIT forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Price to earnings forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Price to sales forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
Ironwood Pharmaceuticals stock follows its own business case. IRWD trades on Nasdaq. - Ad Hoc News
Ironwood Pharmaceuticals (IRWD) Gains From Strong Fiscal Q1 2026 Earnings Momentum - Yahoo Finance
Price to book forward of Ironwood Pharmaceuticals, Inc. – NASDAQ:IRWD - TradingView
IRWD Forecast — Price Target — Prediction for 2027 - TradingView
Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com
Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker - The Globe and Mail
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (BX:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (SWB:I76) - TradingView
Ironwood Pharmaceuticals, Inc. Class A Actuals & Estimates (MUN:I76) - TradingView
I76 Forecast — Price Target — Prediction for 2027 - TradingView
5 Small Drug Stocks to Invest in Amid a Biotech Comeback - Yahoo Finance
Ironwood Pharmaceuticals (IRWD) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Ironwood Pharmaceuticals Inc (IRWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Ironwood Pharmaceuticals StockAnalyst snapshot and sector review at week’s end - AD HOC NEWS
IRWD News | IRONWOOD PHARMACEUTICALS INC (NASDAQ:IRWD) - ChartMill
Ironwood Pharmaceuticals (IRWD) adds 10M shares to 2019 equity incentive plan - Stock Titan
Ironwood Pharmaceuticals Inc - TradingKey
아이언우드 제약 (IRWD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.08%
0.17%
자본화:
|
볼륨(24시간):